ChargePoint reports 399% growth in China

By Flora Southey contact

- Last updated on GMT

After announcing expansion plans across the Americas, ChargePoint says it is growing its presence in Asia.

ChargePoint Technology, which makes powder containment and aseptic transfer valves for powder, granular and semi-solid drug ingredients, has announced a triple-digit growth in Asian markets.

According to the Liverpool, UK-headquartered firm, the first five months of 2018 have seen sales grow 399% in China and 59% in Japan, “leading to an overall Asia growth in sales of over 102% compared to the same period in 2017.”

“The success reflects our commercial strategy to expand the company in key markets during 2018,” ​said CCO Tony O’Sullivan.

“ChargePoint’s unique offering is its split butterfly valve (SBV) technology which continues to grow in popularity worldwide, with the industry adopting it as an improvement to costly containment and sterile transfer solutions,” ​he added.

The news follows the firm’s expansion plans – announced in July 2017​ – to increase its offering across the US, Canada, Mexico and Puerto Rico.

Related news

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Follow us


View more